Literature DB >> 10150821

Lacrimal disease.

R E Wesley1.   

Abstract

Several authors have investigated the success of nasolacrimal duct intubation in children as well as the length of time for tubes to remain in place. The treatment of congenital amniocele with potential for life-threatening septicemia has been investigated. Other topics have included the bacteriology of dacryocystitis emphasizing the risk of endophthalmitis after intraocular surgery, balloon treatment for functional nasolacrimal duct obstruction, anatomical measurements of the lacrimal system relative to intracranial space, and new procedures for punctal stenosis. Diagnostic tests for epiphora and methods of punctal occlusion are evaluated.

Entities:  

Mesh:

Year:  1994        PMID: 10150821

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  5 in total

1.  The Pre-Sac Reflux Test (PSRT): a new diagnostic test for presaccal stenosis/obstruction.

Authors:  Jongyeop Park; Hochang Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-31       Impact factor: 3.117

Review 2.  Ocular infections due to anaerobic bacteria.

Authors:  I Brook
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

3.  The electromyographic analysis of orbicularis oculi muscle in epiphora.

Authors:  Titap Yazicioglu; Rahsan Inan; Anıl Agaçkesen; Murat Oklar; Saban Şimşek
Journal:  Indian J Ophthalmol       Date:  2022-06       Impact factor: 2.969

Review 4.  Lacrimal outflow mechanisms and the role of scintigraphy: current trends.

Authors:  Efstathios T Detorakis; Athanassios Zissimopoulos; Konstantinos Ioannakis; Vassilios P Kozobolis
Journal:  World J Nucl Med       Date:  2014-01

5.  Three-Dimensional Reconstruction of the Bony Nasolacrimal Canal by Automated Segmentation of Computed Tomography Images.

Authors:  Lucia Jañez-Garcia; Federico Saenz-Frances; Jose M Ramirez-Sebastian; Nicolas Toledano-Fernandez; Maria Urbasos-Pascual; Luis Jañez-Escalada
Journal:  PLoS One       Date:  2016-05-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.